Literature DB >> 3566940

Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report.

R H Miller, G E Woodson, J Jankovic.   

Abstract

A number of different therapies have been used in the management of spasmodic dysphonia. None are curative, and the results of the most widely used surgical procedure (resection of the recurrent laryngeal nerve) are not universally good, with a high recurrence rate in some series. Furthermore, the procedure is not reversible. Using a special electromyographic hypodermic needle, we injected botulinum A toxin into one of the vocal folds of two patients with severe spasmodic dysphonia. Both had significant improvement without any complications. Although the resultant paresis is not permanent, the injection can be repeated as needed as an outpatient procedure.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3566940     DOI: 10.1001/archotol.1987.01860060029009

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  17 in total

Review 1.  Distal esophageal spasm: an update.

Authors:  Sami R Achem; Lauren B Gerson
Journal:  Curr Gastroenterol Rep       Date:  2013-09

2.  Intrinsic properties of the adult human mylohyoid muscle: neural organization, fiber-type distribution, and myosin heavy chain expression.

Authors:  Min Ren; Liancai Mu
Journal:  Dysphagia       Date:  2005       Impact factor: 3.438

3.  Botulinum toxin for treatment of spastic dysphonia.

Authors:  C Anonsen
Journal:  West J Med       Date:  1989-04

4.  Spasmodic laryngeal dyspnea: a rare manifestation of laryngeal dystonia.

Authors:  P Zwirner; D Dressler; E Kruse
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

Review 5.  Electromyography and the study of oropharyngeal swallowing.

Authors:  A L Perlman
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

6.  The use of botulinum toxin in the treatment of adductor spasmodic dysphonia.

Authors:  R Whurr; M Lorch; H Fontana; G Brookes; A Lees; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

7.  Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.

Authors:  J Jankovic; K Schwartz; D T Donovan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

8.  Treatment of cervical dystonia hand spasms and laryngeal dystonia with botulinum toxin.

Authors:  A J Lees; N Turjanski; J Rivest; R Whurr; M Lorch; G Brookes
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

9.  A comparison of bilateral and unilateral botulinum toxin treatments for spasmodic dysphonia.

Authors:  P Zwirner; T Murry; G E Woodson
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

10.  Unilateral versus bilateral thyroarytenoid Botulinum toxin injections in adductor spasmodic dysphonia: a prospective study.

Authors:  Tahwinder Upile; Behrad Elmiyeh; Waseem Jerjes; Vyas Prasad; Panagiotis Kafas; Jesuloba Abiola; Bryan Youl; Ruth Epstein; Colin Hopper; Holger Sudhoff; John Rubin
Journal:  Head Face Med       Date:  2009-10-24       Impact factor: 2.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.